Diagnosed cases of sepsis exceed 18 million a year with 1,400 patients dying daily in the developed world. Rapid treatment is critical to a patient’s recovery and therefore the time taken to diagnose sepsis is key. This technology can diagnose sepsis in the patient before symptoms appear which has the potential to save many lives and reduce economic costs.
For more information about licensing this technology, or to speak to us about our other life sciences related intellectual property, please contact us
Ploughshare is your gateway to a portfolio of world-class life science and other technology solutions from Dstl, the MOD’s research and development division.